Bulletin from Moberg Pharma's AGM 2018
Bulletin from Moberg Pharma's AGM 2018 |
[15-May-2018] |
STOCKHOLM, May 15, 2018 /PRNewswire/ -- Moberg Pharma AB's ("Company") Annual General Meeting took place on Tuesday, May 15th, 2018 in the Company´s premises in Bromma. Adoption of the income statements and the balance sheets The Meeting resolved, in accordance with the proposal of the Board of Directors, that no dividend should be paid for the fiscal year 2017. The Meeting discharged the Board members and the Chief Executive Officer from liability for the fiscal year 2017. Board of Directors The Meeting resolved re-election of the Board Directors Thomas Eklund (Chairman), Geert Cauwenbergh, Sara Brandt and Mattias Klintemar, and election of Anna Malm Bernsten as new member, until the end of the next Annual General Meeting. Torbjörn Koivisto and Thomas B. Thomsen have chosen, after nine years and four years as Board Directors, to resign. The Meeting resolved, in accordance with the proposal of the Nomination Committee, that an aggregate fee to Board members of SEK 1,220,000 shall be paid to the Board Directors, of which SEK 360,000 to the Chairman and SEK 170,000 for all other Board Directors elected by the Annual General Meeting. An additional fee of SEK 90,000 shall be paid to the members of the Remuneration Committee, SEK 45,000 to the chairman and SEK 22,500 to the other members (2). A fee of SEK 90,000 shall be paid to the members of the Audit and Finance Committee, SEK 45,000 to the chairman and SEK 22,500 to the other members (2). Fees to the Auditors, for a period until the end of the next Annual General Meeting, are to be paid as per approved invoice. Nomination Committee Principles for remuneration Implementation of LTI 2018 Authorization to issue share About this information For additional information, please contact: This information was brought to you by Cision http://news.cision.com http://news.cision.com/moberg-pharma/r/bulletin-from-moberg-pharma-s-agm-2018,c2521050 The following files are available for download:
View original content:http://www.prnewswire.com/news-releases/bulletin-from-moberg-pharmas-agm-2018-300648885.html SOURCE Moberg Pharma | ||||
Company Codes: Bloomberg:MOB@SS, ISIN:SE0003613090, RICS:MOB.ST, Stockholm:MOB |
© 2018 PR Newswire. All Rights Reserved.